<DOC>
	<DOCNO>NCT00620854</DOCNO>
	<brief_summary>This study compare performance different dose oral recombinant salmon calcitonin ( rsCT ) .</brief_summary>
	<brief_title>A Dose Selection Study Oral Recombinant Salmon Calcitonin ( rsCT ) Normal , Healthy , Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Salmon calcitonin</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<mesh_term>Calcitonin Gene-Related Peptide</mesh_term>
	<criteria>Postmenopausal female , good health ( least 5 year since last menses ) Age ≥45 ≤70 Weight + 20 % Metropolitan Life weight table Plasma Cterminal telopeptide type I collagen ( CTx1 ) ≥ 0.25 ng/mL Total calcium ( Ca++ ) , phosphorus ( P ) , magnesium ( Mg++ ) within normal range Willing able comply study requirement Willing able sign write informed consent Negative urine pregnancy test screen Negative Screen Hepatitis B C , human immunodeficiency virus ( HIV ) drug abuse History parathyroid , thyroid , pituitary adrenal disease History musculoskeletal disease History gastroesophageal reflux disease ( GERD ) significant gastrointestinal disorder History cancer within 5 year enrollment basal cell carcinoma History regular use nonsteroidal antiinflammatory drug ( NSAID ) History surgery within 60 day enrollment History hypersensitivity allergy ( seasonal allergy ) within 5 year enrollment include known sensitivity active ingredient excipients study medication Use concomitant medication acetaminophen within 7 day enrollment anticipate need use concomitant medication study Use bisphosphonates within 6 month , selective selective estrogen receptor modulators ( SERMS ) , estrogen estrogenlike drug 2 month , calcitonin 1 month Presence clinically significant illness Unwilling unable comply study requirement Unwilling unable sign write , informed consent History drug alcohol abuse Participation clinical study investigational drug within 60 day enrollment Plasma CTx1 le 0.25 ng/mL</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>